Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
700 μg DEX PS DDS 植入系统治疗BRVO或CRVO导致黄斑水肿的中国患者的安全性和疗效
CTR20130143Phase 3Completed
- Sponsor
- Allergan
- Start
- Aug 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in macular edema, branch retinal vein occlusion (BRVO), central retinal vein occlusion (CRVO), sponsored by Allergan. Started Aug 2014; status: completed.
02
Drugs
dexamethasone
03
Conditions
macular edemabranch retinal vein occlusion (BRVO)central retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on CTR20130143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130143.